Amazing work by Binbin, Ethan, and the rest of the team at vcreate. This is an incredibly thoughtful and rigorous study—congratulations to everyone involved!
Excited to share our new preprint: an integrated platform for discovering HLA-E–presented cancer antigens. Why HLA-E? It's carried by 99% of humans — meaning HLA-E presented targets could apply across many patients and cancer types. 🧵